Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- Nursing Care Insurance Boosts Market for Welfare Appliances
February 19, 2001
- REGULATORY NEWS IN BRIEF
February 12, 2001
- Asahi Chemical, Janssen-Kyowa to Make Utmost Efforts to Expand Japan's 1st SNRI Market
February 12, 2001
- NDA Review System Should Be Reformed as Part of Administrative Reform: New ELD Director
February 12, 2001
- Demographic Estimates for 2000 Show More Births: Koseisho
February 12, 2001
- EMA Proposes Measures to Encourage Use of Generics
February 12, 2001
- Korosho to Issue Notification in May to Introduce CTD
February 12, 2001
- Record-low Population Growth Rate Marked: Nat'l Census
February 12, 2001
- Senshu Yakuhin Restarts Business as Subsidiary of Kuraya Sanseido
February 12, 2001
- Kemporen Calls For Elimination of Financial Contribution to Elderly Healthcare
February 12, 2001
- 39 Monodrugs, 2 Combination Drugs Designated: Quality Reevaluation
February 12, 2001
- Mochida to Prevail through R&D, Alliance, Emphasis on Results
February 12, 2001
- Keisansho to Promote Healthcare Services as Industry
February 12, 2001
- REGULATORY NEWS IN BRIEF -2-
February 12, 2001
- Dainippon to Withdraw Aleviatin Fine Granules
February 12, 2001
- Drug Makers Must Assume Full Responsibility for Their Products
February 12, 2001
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
February 12, 2001
- Bayer Yakuhin, Meiji Seika to Comarket Ciproxan
February 12, 2001
- Japan Not to Introduce Inactivated Vaccine against Polio
February 12, 2001
- Combination Therapy with Protopic, Steroid Reported: Fujisawa Seminar
February 12, 2001
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…